Regina Beets-Tan on MRI, AI, Multidisciplinary Collaboration

That matters to patients because rectal cancer treatment has shifted decisively away from a fixed, one-size-fits-all pathway.

Where MRI today can identify which tumours need pre-operative radiotherapy, plan surgery, measure response and even select patients for organ-preserving strategies, the same scan two decades ago largely served to show the tumour's anatomical extent.

MRI Guides Rectal Cancer Treatment Choices

  • An MRI in rectal cancer is no longer just a picture; it can help determine whether a patient needs radiotherapy before surgery, or whether surgery can be safely avoided altogether.
  • Radiologists are increasingly expected to act as “medical information specialists” — integrating imaging with pathology, laboratory and genetic data — rather than simply reading images in isolation.
  • Artificial intelligence tools must be validated in each hospital’s own patient population before clinicians and patients should trust them; a strong result in a research setting does not guarantee value in local practice.

From Diagnostic Scan to Treatment Decision-Maker

The clearer picture allowed clinicians to identify patients whose tumours extended into surrounding structures — the mesorectum and its surrounding fascia — and who therefore needed radiotherapy before surgery rather than immediate operation.

“Imaging therefore moved from simply showing us the disease to helping determine the most appropriate treatment from the outset,” she told European Medical Journal.

Since then, repeated MRI after radiotherapy has enabled so-called watch-and-wait strategies: patients whose tumours show a complete response may avoid surgery altogether, sparing them the toxicity and functional consequences of major pelvic operation.

The next frontier, she said, is integration — combining imaging with pathology, laboratory and molecular biomarkers and clinical data, increasingly supported by artificial intelligence. “The question will no longer simply be ‘what do we see?’, but increasingly ‘what does all this information mean for this individual patient, and how should it change treatment?'”

AI as an Orchestrator, Not a Replacement

She said AI will change the specialty "much more profoundly than simply helping us acquire scans and interpret images faster," because it can merge information that today sits in separate departments. Traditional silos may break down, and with them the old model of the imaging report arriving at the end of a diagnostic process.

“The goal is not AI replacing one professional or another; the goal is AI helping us make better decisions together,” she told European Medical Journal.

She also issued a caution that clinicians and journalists alike should carry forward: technological performance is not clinical value. In her assessment, an AI tool must be validated across hospitals and patient groups, work reliably in local practice, fit into clinical workflows and demonstrably improve decisions before it earns a place in care.

She now coordinates Compass AI, a flagship project under the European Commission’s Apply AI Strategy aimed at accelerating safe implementation in healthcare, and previously served on the European Commission’s Mission Board for Cancer.

Why Collaboration, Not Hardware, Wins the Next Decade

Collaboration ran through the interview as the consistent theme. At ECR 2022 she chose "Building Bridges" as the congress theme, deliberately inviting other disciplines and policymakers into dialogue with radiologists.

For policy, she argues that innovation cannot stay confined to specialised centres. "An innovation has limited value if it works in only one research centre or highly specialised institution," she said, adding that policy must start with clinical reality — thorough local validation, workflow integration, clarity about responsibility, and the trust of healthcare professionals and patients.

Her message to the next generation at UEG Week, which welcomed over 14,000 delegates this year in its largest congress to date, was blunt: work across disciplines. “A Lifetime Achievement Award may carry one person’s name, but it is never the achievement of one person,” she said, crediting patients who joined studies and colleagues across many disciplines.

MRI Restaging Enables Organ-Preserving Options

The practical consequence of this work is already visible in European practice pathways: MRI-based restaging after chemoradiotherapy now underpins organ-preserving options in selected patients in specialist centres, with multidisciplinary review before any treatment decision.

Imaging Advance Role in Rectal Cancer Care Patient Impact Described by Beets-Tan
Repeat MRI after radiotherapy Assessing complete tumour response Possible organ-preserving “watch-and-wait” follow-up
Multimodal data + AI Integrating imaging, pathology, molecular biomarkers Personalised treatment selection; breakdown of departmental silos

Report Addresses System Change, Not Treatment

This report concerns health system change, not treatment advice.

The award, presented at UEG Week 2026, closes one chapter and opens another: a discipline redefining itself from picture-reading to information integration.

References

  • United European Gastroenterology (UEG) — UEG Week 2026 congress programme and Lifetime Achievement Award citation
  • European Society of Radiology (ESR) — European Congress of Radiology 2022, “Building Bridges” theme
  • European Commission — Apply AI Strategy; Compass AI flagship project; Mission Board for Cancer
Photo of author

Health Desk

Health Desk at Archyde.

NHL Unveils Winter Classic Jerseys for Utah Mammoth, Colorado Avalanche